Mouse forestomach carcinoma cells immunosuppress macrophages through transforming growth factor-β1

Molecular Medicine Reports

Volumn 5, Issue 4, 2012, Pages 988-992

  Luo, Huaxing ^a   Hao, Yingxue ^a   Tang, Bo ^a   Zeng, Dongzhu ^a   Shi, Yan ^a   Yu, Peiwu ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Immunosuppression; Macrophages; Mouse forestomach carcinoma cells; Transforming growth factor 1

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 1BETA; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA1; VASCULOTROPIN;

ANIMAL CELL; ARTICLE; CARCINOMA CELL; CELL POLARITY; COLORIMETRY; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOREGULATION; MACROPHAGE FUNCTION; MALE; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PERITONEUM METASTASIS; PHAGOCYTOSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STOMACH CARCINOMA; WESTERN BLOTTING;

ANIMALS; CARCINOMA; CELLS, CULTURED; CULTURE MEDIA, CONDITIONED; IMMUNOSUPPRESSION; MACROPHAGES, PERITONEAL; MALE; MICE; MICE, INBRED C57BL; PERITONEUM; PHAGOCYTOSIS; SIGNAL TRANSDUCTION; STOMACH NEOPLASMS; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84858259429     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2012.777     Document Type: Article

References (20)

1. Moriguchi S, Maehara Y, Korenaga D, Sugimachi K and Nose Y: Risk factors which predict pattern of recurrence after curative surgery for patients with advanced gastric cancer. Surg Oncol 1: 341-346, 1992.
2. Ribeiro U Jr, Gama-Rodrigues JJ, Safatle-Ribeiro AV, et al: Prognostic significance of intraperitoneal free cancer cells obtained by laparoscopic peritoneal lavage in patients with gastric cancer. J Gastrointest Surg 2: 244-249, 1998. (Pubitemid 128409610)
3. Bando E, Yonemura Y, Takeshita Y, et al: Intraoperative lavage for cytological examination in 1,297 patients with gastric carcinoma. Am J Surg 178: 256-262, 1999. (Pubitemid 29475109)
4. Yoo CH, Noh SH, Shin DW, Choi SH and Min JS: Recurrence following curative resection for gastric carcinoma. Br J Surg 87: 236-242, 2000. (Pubitemid 30088655)
5. Maruyama K, Selmani Z, Ishii H and Yamaguchi K: Innate immunity and cancer therapy. Int Immunopharmacol 11: 350-357, 2011.
6. Oosterling SJ, van der Bij GJ, Bogels M, van der Sijp JR, Beelen RH, Meijer S and van Egmond M: Insufficient ability of omental milky spots to prevent peritoneal tumor outgrowth supports omentectomy in minimal residual disease. Cancer Immunol Immunother 55: 1043-1051, 2006. (Pubitemid 43800719)
7. Mantovani A, Sozzani S, Locati M, Allavena P and Sica A: Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol 23: 549-555, 2002. (Pubitemid 35223554)
8. Mantovani A, Sica A, Sozzani S, Allavena P, Vecchi A and Locati M: The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol 25: 677-686, 2004. (Pubitemid 39457982)
9. Mantovani A and Sica A: Macrophages, innate immunity and cancer: balance, tolerance, and diversity. Curr Opin Immunol 22: 231-237, 2010.
10. Qian SS, Gao J, Wang JX, Liu Y and Dong HY: Establishment of a mouse forestomach carcinoma cell line with spontaneous hematogenous metastasis and preliminary study of its biological characteristics. Zhonghua Zhong Liu Za Zhi 9: 261-264, 1987.
11. Mosser DM and Edwards JP: Exploring the full spectrum of macrophage activation. Nat Rev Immunol 8: 958-969, 2008.
12. Goerdt S and Orfanos CE: Other functions, other genes: alternative activation of antigen-presenting cells. Immunity 10: 137-142, 1999. (Pubitemid 29115619)
13. Benson SA and Ernst JD: TLR2-dependent inhibition of macrophage responses to IFN-γ is mediated by distinct, gene-specific mechanisms. PLoS One 4: e6329, 2009.
14. Wu A, Wei J, Kong LY, et al: Glioma cancer stem cells induce immunosuppressive macrophages/microglia. Neuro Oncol 12: 1113-1125, 2010.
15. O'Brien J and Schedin P: Macrophages in breast cancer: do involution macrophages account for the poor prognosis of pregnancy-associated breast cancer? J Mammary Gland Biol Neoplasia 14: 145-157, 2009.
16. Li YW, Qiu SJ, Fan J, et al: Tumor-infiltrating macrophages can predict favorable prognosis in hepatocellular carcinoma after resection. J Cancer Res Clin Oncol 135: 439-449, 2009.
17. Blobe GC, Schiemann WP and Lodish HF: Role of transforming growth factor β in human disease. N Engl J Med 342: 1350-1358, 2000. (Pubitemid 30408720)
18. Inman GJ: Switching TGFβ from a tumor suppressor to a tumor promoter. Curr Opin Genet Dev 21: 93-99, 2011.
19. Lin Y, Kikuchi S, Obata Y and Yagyu K: Serum levels of transforming growth factor β1 are significantly correlated with venous invasion in patients with gastric cancer. J Gastroenterol Hepatol 21: 432-437, 2006.
20. Shinto O, Yashiro M, Kawajiri H, Shimizu K, Shimizu T, Miwa A and Hirakawa K: Inhibitory effect of a TGFβ receptor type-I inhibitor, Ki26894, on invasiveness of scirrhous gastric cancer cells. Br J Cancer 102: 844-851, 2010.